Blue Chip Partners, Inc. Merck & Co., Inc. Transaction History

Blue Chip Partners, Inc.

$1.15 Billion
Q3 2024

A detailed history of Blue Chip Partners, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Blue Chip Partners, Inc. holds 168,416 shares of MRK stock, worth $16.5 Million. This represents 1.66% of its overall portfolio holdings.

Number of Shares

168,416

Previous 162,639 3.55%

Holding current value

$16.5 Million

Previous $20.1 Million 5.01%

% of portfolio

1.66%

Previous 1.86%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$111.15 - $128.97 $642,113 - $745,059	5,777 Added 3.55%	168,416 $19.1 Million
Q2 2024 Jul 29, 2024	BUY	$123.8 - $132.96 $861,771 - $925,534	6,961 Added 4.47%	162,639 $20.1 Million
Q1 2024 Apr 25, 2024	BUY	$113.24 - $131.95 $1.51 Million - $1.76 Million	13,303 Added 9.34%	155,678 $20.5 Million
Q4 2023 Feb 05, 2024	BUY	$100.18 - $109.02 $1.58 Million - $1.72 Million	15,757 Added 12.44%	142,375 $15.5 Million
Q3 2023 Oct 30, 2023	BUY	$102.95 - $114.33 $10.6 Million - $11.8 Million	103,142 Added 439.35%	126,618 $13 Million
Q2 2023 Aug 02, 2023	SELL	$108.61 - $118.38 $32,474 - $35,395	-299 Reduced 1.26%	23,476 $2.71 Million
Q1 2023 May 01, 2023	SELL	$102.94 - $114.86 $131,969 - $147,250	-1,282 Reduced 5.12%	23,775 $2.53 Million
Q4 2022 Feb 01, 2023	SELL	$87.44 - $112.11 $73,187 - $93,836	-837 Reduced 3.23%	25,057 $2.78 Million
Q3 2022 Oct 27, 2022	BUY	$84.53 - $94.96 $15,891 - $17,852	188 Added 0.73%	25,894 $2.23 Million
Q2 2022 Aug 01, 2022	BUY	$83.49 - $94.64 $29,972 - $33,975	359 Added 1.42%	25,706 $2.34 Million
Q1 2022 May 04, 2022	SELL	$73.51 - $82.4 $100,929 - $113,135	-1,373 Reduced 5.14%	25,347 $2.08 Million
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $16,407 - $20,552	227 Added 0.86%	26,720 $2.05 Million
Q3 2021 Nov 02, 2021	SELL	$71.68 - $78.83 $72,396 - $79,618	-1,010 Reduced 3.67%	26,493 $1.99 Million
Q2 2021 Aug 03, 2021	SELL	$70.31 - $77.77 $81,700 - $90,368	-1,162 Reduced 4.05%	27,503 $2.14 Million
Q1 2021 May 04, 2021	SELL	$68.86 - $81.11 $112,930 - $133,020	-1,640 Reduced 5.41%	28,665 $2.21 Million
Q4 2020 Feb 05, 2021	SELL	$71.77 - $79.65 $199,305 - $221,188	-2,777 Reduced 8.39%	30,305 $2.48 Million
Q3 2020 Oct 27, 2020	SELL	$73.18 - $82.95 $32,638 - $36,995	-446 Reduced 1.33%	33,082 $2.74 Million
Q2 2020 Jul 30, 2020	SELL	$70.42 - $80.13 $89,926 - $102,326	-1,277 Reduced 3.67%	33,528 $2.59 Million
Q1 2020 May 08, 2020	SELL	$63.36 - $87.82 $276,059 - $382,631	-4,357 Reduced 11.13%	34,805 $2.68 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $89,061 - $100,495	1,148 Added 3.02%	39,162 $3.56 Million
Q3 2019 Oct 29, 2019	BUY	$76.08 - $82.93 $180,005 - $196,212	2,366 Added 6.64%	38,014 $3.2 Million
Q2 2019 Jul 31, 2019	BUY	$69.84 - $81.59 $43,719 - $51,075	626 Added 1.79%	35,648 $2.99 Million
Q1 2019 Apr 23, 2019	BUY	$69.58 - $79.36 $16,420 - $18,728	236 Added 0.68%	35,022 $2.91 Million
Q4 2018 Feb 05, 2019	SELL	$65.24 - $75.71 $76,852 - $89,186	-1,178 Reduced 3.28%	34,786 $2.66 Million
Q3 2018 Oct 26, 2018	SELL	$57.69 - $67.84 $66,978 - $78,762	-1,161 Reduced 3.13%	35,964 $2.55 Million
Q2 2018 Jul 25, 2018	SELL	$50.83 - $59.72 $156,048 - $183,340	-3,070 Reduced 7.64%	37,125 $2.25 Million
Q1 2018 Apr 25, 2018	SELL	$50.96 - $59.23 $216,376 - $251,490	-4,246 Reduced 9.55%	40,195 $2.19 Million
Q4 2017 Jan 31, 2018	SELL	$51.62 - $61.64 $126,417 - $150,956	-2,449 Reduced 5.22%	44,441 $2.5 Million
Q3 2017 Nov 07, 2017	SELL	$58.67 - $63.13 $40,892 - $44,001	-697 Reduced 1.46%	46,890 $3 Million
Q2 2017 Aug 07, 2017	BUY	N/A	47,587	47,587 $3.05 Million

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.

Account

Blue Chip Partners, Inc. Merck & Co., Inc. Transaction History